DexCom Long Term Debt 2010-2025 | DXCM
DexCom long term debt from 2010 to 2025. Long term debt can be defined as the sum of all long term debt fields.
- DexCom long term debt for the quarter ending March 31, 2025 was $1.238B, a 49.18% decline year-over-year.
- DexCom long term debt for 2024 was $1.237B, a 49.18% decline from 2023.
- DexCom long term debt for 2023 was $2.434B, a 103.24% increase from 2022.
- DexCom long term debt for 2022 was $1.198B, a 39.57% decline from 2021.
| DexCom Annual Long Term Debt (Millions of US $) |
|
|---|---|
| 2024 | $1,237 |
| 2023 | $2,434 |
| 2022 | $1,198 |
| 2021 | $1,982 |
| 2020 | $1,667 |
| 2019 | $1,060 |
| 2018 | $1,010 |
| 2017 | $328 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $2 |
| 2013 | $5 |
| 2012 | $7 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $46 |
| DexCom Quarterly Long Term Debt (Millions of US $) |
|
|---|---|
| 2025-03-31 | $1,238 |
| 2024-12-31 | $1,237 |
| 2024-09-30 | $2,440 |
| 2024-06-30 | $2,438 |
| 2024-03-31 | $2,436 |
| 2023-12-31 | $2,434 |
| 2023-09-30 | $2,432 |
| 2023-06-30 | $2,431 |
| 2023-03-31 | $1,199 |
| 2022-12-31 | $1,198 |
| 2022-09-30 | $1,969 |
| 2022-06-30 | $1,967 |
| 2022-03-31 | $1,966 |
| 2021-12-31 | $1,982 |
| 2021-09-30 | $1,704 |
| 2021-06-30 | $1,711 |
| 2021-03-31 | $1,689 |
| 2020-12-31 | $1,667 |
| 2020-09-30 | $1,646 |
| 2020-06-30 | $1,659 |
| 2020-03-31 | $1,072 |
| 2019-12-31 | $1,060 |
| 2019-09-30 | $1,047 |
| 2019-06-30 | $1,035 |
| 2019-03-31 | $1,022 |
| 2018-12-31 | $1,010 |
| 2018-09-30 | $339 |
| 2018-06-30 | $335 |
| 2018-03-31 | $331 |
| 2017-12-31 | $328 |
| 2017-09-30 | $324 |
| 2017-06-30 | $321 |
| 2017-03-31 | |
| 2016-12-31 | |
| 2016-09-30 | |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | $0 |
| 2015-06-30 | $1 |
| 2015-03-31 | $2 |
| 2014-12-31 | $2 |
| 2014-09-30 | $3 |
| 2014-06-30 | $4 |
| 2014-03-31 | $4 |
| 2013-12-31 | $5 |
| 2013-09-30 | $5 |
| 2013-06-30 | $6 |
| 2013-03-31 | $6 |
| 2012-12-31 | $7 |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | |
| 2010-09-30 | $1 |
| 2010-06-30 | $3 |
| 2010-03-31 | $5 |
| 2009-12-31 | $46 |
| 2009-09-30 | $45 |
| 2009-06-30 | $2 |
| 2009-03-31 | $43 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $32.894B | $4.033B |
| DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $185.883B | 81.42 |
| Thermo Fisher Scientific (TMO) | United States | $156.566B | 18.94 |
| Edwards Lifesciences (EW) | United States | $44.869B | 29.42 |
| Alcon (ALC) | Switzerland | $43.085B | 29.12 |
| IDEXX Laboratories (IDXX) | United States | $41.386B | 47.56 |
| IQVIA Holdings (IQV) | United States | $27.789B | 15.56 |
| Mettler-Toledo (MTD) | United States | $24.832B | 29.53 |
| STERIS (STE) | Ireland | $22.191B | 24.44 |
| SONOVA HOLDING (SONVY) | Switzerland | $17.420B | 0.00 |
| Waters (WAT) | United States | $17.111B | 24.14 |
| Hologic (HOLX) | United States | $14.260B | 15.49 |
| Sysmex ADR (SSMXY) | Japan | $10.443B | 29.62 |
| Penumbra (PEN) | United States | $8.922B | 70.02 |
| Masimo (MASI) | United States | $8.375B | 30.89 |
| Globus Medical (GMED) | United States | $7.627B | 18.17 |
| Glaukos (GKOS) | United States | $5.583B | 0.00 |
| Teleflex (TFX) | United States | $4.908B | 8.10 |
| Integer Holdings (ITGR) | United States | $3.925B | 20.57 |
| TransMedics (TMDX) | United States | $3.717B | 80.79 |
| PROCEPT BioRobotics (PRCT) | United States | $3.228B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.289B | 13.63 |
| Elekta AB (EKTAY) | Sweden | $1.899B | 17.07 |
| Nihon Kohden (NHNKY) | Japan | $1.863B | 21.37 |
| Veracyte (VCYT) | United States | $1.841B | 25.83 |
| Alphatec Holdings (ATEC) | United States | $1.533B | 0.00 |
| Artivion (AORT) | United States | $1.302B | 121.96 |
| OPKO Health (OPK) | United States | $1.071B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.016B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.984B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.865B | 4.60 |
| IRadimed (IRMD) | United States | $0.721B | 36.57 |
| SiBone (SIBN) | United States | $0.708B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.589B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.569B | 12.24 |
| OrthoPediatrics (KIDS) | United States | $0.535B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.519B | 8.07 |
| AxoGen (AXGN) | United States | $0.514B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.416B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.411B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.392B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.385B | 8.96 |
| Treace Medical Concepts (TMCI) | United States | $0.355B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.353B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.309B | 0.00 |
| RxSight (RXST) | United States | $0.299B | 0.00 |
| NeuroPace (NPCE) | United States | $0.297B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.258B | 0.00 |
| Neuronetics (STIM) | United States | $0.242B | 0.00 |
| 908 Devices (MASS) | United States | $0.240B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.221B | 13.41 |
| CVRx (CVRX) | United States | $0.209B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.202B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.181B | 0.00 |
| Inogen (INGN) | United States | $0.171B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.171B | 0.00 |
| LENSAR (LNSR) | United States | $0.154B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.149B | 0.00 |
| Accuray (ARAY) | United States | $0.138B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.126B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.121B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.110B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.109B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.087B | 0.00 |
| InspireMD (NSPR) | United States | $0.073B | 0.00 |
| Hyperfine (HYPR) | United States | $0.072B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.071B | 43.40 |
| Spectral AI (MDAI) | United States | $0.064B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.061B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.060B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.057B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 21.11 |
| Precision Optics (POCI) | United States | $0.036B | 0.00 |
| Envoy Medical (COCH) | United States | $0.034B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.022B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.021B | 0.00 | |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.018B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.011B | 0.00 |
| PAVmed (PAVM) | United States | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.005B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 15.17 |